Atherosclerosis 1991
DOI: 10.1007/978-1-4615-3754-0_17
|View full text |Cite
|
Sign up to set email alerts
|

Eicosanoid Metabolism and Endothelial Cell Adhesion Molecule Expression: Effects on Platelet/Vessel Wall Interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

1993
1993
2019
2019

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…The CD fat source is soybean oil, which provides 9.14g/kg of PUFAs while the WD, with milk fat provides 7.35g/kg (a decrease in n-3 PUFAS from 1.21 to 1.05 g/kg and n-6 PUFA’s from 7.93 to 6.3). Interestingly, in LDLr -/- mice, we saw an increase in the long chain (20 and 22 carbon) neuroprotective PUFAs [ 101 ], and a decrease in 9-Hydroxy-10,12-octadecadienoic acid (9-HODE), a pro-inflammatory mediator [ 102 ] and 13-HODE, shown to regulate platelet vessel wall adhesion [ 103 , 104 ], and commonly associated with a protective effect. This may be due to a shift in the types or quantities of lipids normally delivered across the BBB [ 81 ].…”
Section: Discussionmentioning
confidence: 99%
“…The CD fat source is soybean oil, which provides 9.14g/kg of PUFAs while the WD, with milk fat provides 7.35g/kg (a decrease in n-3 PUFAS from 1.21 to 1.05 g/kg and n-6 PUFA’s from 7.93 to 6.3). Interestingly, in LDLr -/- mice, we saw an increase in the long chain (20 and 22 carbon) neuroprotective PUFAs [ 101 ], and a decrease in 9-Hydroxy-10,12-octadecadienoic acid (9-HODE), a pro-inflammatory mediator [ 102 ] and 13-HODE, shown to regulate platelet vessel wall adhesion [ 103 , 104 ], and commonly associated with a protective effect. This may be due to a shift in the types or quantities of lipids normally delivered across the BBB [ 81 ].…”
Section: Discussionmentioning
confidence: 99%
“…NO and prostacyclin, which inhibit platelet adhesion and aggregation, are constitutively released by endothelial cells (223). 3-hydroxyoctadecadienoic acid, synthesized via lipoxygenase pathways in resting endothelial cells, inhibit platelet aggregation by acting as a negative regulator for the adhesion receptor vitronectin (35, 36). Membrane-bound ectonucleotidases on cell surface of endothelial cells metabolize ATP and ADP to prevent platelet activation (191, 289).…”
Section: Functions Of the Endotheliummentioning
confidence: 99%
“…Interestingly, exposure of endothelial cells to HPODE can have beneficial effects. For example, the hydroxyderivative of HPODE, HODE inhibits platelet aggregation (36,37) and production of thromboxane (38). In addition, HPODE has been shown to stimulate prostacyclin synthesis by the endothelium, which may have antiatherogenic effects (39).…”
Section: Discussionmentioning
confidence: 99%